ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 96

The ABCG2 polymorphism Is Associated with Hyperuricemia in a Community-Based Korean Cohort

Jae-Bum Jun1, Hye-Jin Jeong2, Chang-Nam Son3, Ji-Min Kim3, Sang-Hyon Kim3, So-Young Bang4 and Sang-Cheol Bae1, 1Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 2Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea, 4Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Hyperuricemia and polymorphism

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Genetics, Genomics and Proteomics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Hyperuricemia is known as a risk factor of diverse diseases such as gout, hypertension, metabolic syndrome, diabetes mellitus, and cardiovascular diseases. Recent genome-wide association studies (GWASs) have identified that 28 genetic loci are associated with hyperuricemia among individuals of European ancestry. For example, SLC2A9, ABCG2 and SLC22A12 modulate serum uric acid levels (SUAs) in the renal urate-transport system. The purpose of the present study is to find novel loci associated with hyperuricemia using data from a GWAS conducted on healthy Koreans.

Methods: We conducted a GWAS using data from a community-based cohort study where 3,647 subjects aged 40 – 69 were recruited by the Korea National Institute of Health (KNIH). The community-based cohort consisted of subjects who did not suffer from any of six major diseases (hypertension, hyperlipidemia, diabetes, heart diseases, brain diseases, and cancers). Epidemiologic information includes 249 traits such as epidemiological surveys, physical examinations, and laboratory tests. A total of 3,647 participants, including 234 hyperuricemia cases (SUA level was 7 or higher) and 3,413 controls, were genotyped by Illumina HumanOmni1-Quad BeadChip GWAS array at KNIH.

Results: In the multivariate regression analysis of clinical variables, significant variables were male gender (P = 5.0 x 10-10), body mass index (BMI) (P = 1.5 x 10-7), current alcohol (P = 7.8 x 10-7), fasting plasma glucose (FPG) (P = 0.035), and creatinine (P = 2.7 x 10-14). We identified new hyperuricemia susceptible loci (rs2054576 in ABCG2, P = 4.7 x 10-8) that passed a genome-wide significance threshold, adjusted by clinical variables (male, BMI, current alcohol, FPG, and creatinine). 

Conclusion: It was first identified that rs2054576 in ABCG2 is associated with hyperuricemia. ABCG2 is a transporter that is located in the apical border membrane of renal proximal tubule cells and plays a role in uric acid secretion. Our results should be validated through replication studies among other Korean subjects or various ethnic groups.


Disclosure: J. B. Jun, None; H. J. Jeong, None; C. N. Son, None; J. M. Kim, None; S. H. Kim, None; S. Y. Bang, None; S. C. Bae, None.

To cite this abstract in AMA style:

Jun JB, Jeong HJ, Son CN, Kim JM, Kim SH, Bang SY, Bae SC. The ABCG2 polymorphism Is Associated with Hyperuricemia in a Community-Based Korean Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-abcg2-polymorphism-is-associated-with-hyperuricemia-in-a-community-based-korean-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-abcg2-polymorphism-is-associated-with-hyperuricemia-in-a-community-based-korean-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology